- Home
- ABBV vs BA Comparison
ABBV vs BA Comparison
Compare ABBV & BA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABBV | BA |
|---|---|---|
| Founded | 2012 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5B | 182.2B |
| IPO Year | 2012 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ABBV | BA |
|---|---|---|
| Price | $222.22 | $229.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 16 |
| Target Price | $253.71 | ★ $269.75 |
| AVG Volume (30 Days) | 3.6M | ★ 6.0M |
| Earning Date | 04-29-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | N/A | ★ 113.51 |
| EPS | ★ 0.39 | N/A |
| Revenue | $61,160,000,000.00 | ★ $89,463,000,000.00 |
| Revenue This Year | $11.87 | $12.16 |
| Revenue Next Year | $8.12 | $14.78 |
| P/E Ratio | $583.67 | ★ N/A |
| Revenue Growth | 8.57 | ★ 34.50 |
| 52 Week Low | $181.75 | $176.77 |
| 52 Week High | $244.81 | $254.35 |
Technical Indicators
Market Signals| Indicator | ABBV | BA |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 56.34 |
| Support Level | $220.11 | $225.00 |
| Resistance Level | $230.91 | $242.79 |
| Average True Range (ATR) | 5.05 | 6.85 |
| MACD | 0.40 | 0.58 |
| Stochastic Oscillator | 61.57 | 87.89 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About BA Boeing Company (The)
Boeing is a major aerospace and defense firm operating in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed Martin and Northrop Grumman to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.